Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women

Menopause : the Journal of the North American Menopause Society
Jittima ManonaiUrusa Theppisai

Abstract

To evaluate the effect of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women and to evaluate the safety of Pueraria mirifica on endometrium; breast tissue; and hematologic, hepatic, and renal systems. This was a randomized, double-blind, placebo-controlled study in a university hospital of healthy postmenopausal women aged 45 to 60 years old. Women were enrolled voluntarily and randomly received 20, 30, or 50 mg Pueraria mirifica in capsules or identical placebo once daily for 24 weeks. Outcome measures were lipid profiles, bone-specific alkaline phosphatase level, endometrial thickness, endometrial histology, breast ultrasonography, complete blood count, liver function test, and renal function test. After 24 weeks of treatment, 71 women were evaluated. Of the 71 women, 51 randomly received varying doses of Pueraria mirifica and 20 received placebo. Pueraria mirifica and placebo significantly increased triglyceride levels by 15% from baseline levels (P<0.05). The Pueraria mirifica group showed a significant decrease in bone-specific alkaline phosphatase levels after 24 weeks of treatment compared with the placebo group; from 0.22+/-0.18 U/L to 0.13+/-0.01 U/L in th...Continue Reading

References

Nov 1, 1990·Maturitas·J JensenC Christiansen
Sep 1, 1994·The American Journal of Clinical Nutrition·A CassidyK D Setchell
Jan 4, 1993·Atherosclerosis·J C StevensonI F Godsland
Feb 17, 1998·Obstetrics and Gynecology·P AlbertazziD De Aloysio
Mar 10, 1998·Proceedings of the Society for Experimental Biology and Medicine·J J AndersonS C Garner
Oct 24, 1998·Endocrinology and Metabolism Clinics of North America·J C LaRosa
Nov 3, 1998·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P FantiH H Malluche
Nov 5, 1998·Alternative Medicine Review : a Journal of Clinical Therapeutic
Dec 16, 1998·The American Journal of Clinical Nutrition·B H ArjmandiS C Kukreja
Dec 16, 1998·The American Journal of Clinical Nutrition·S M PotterJ W Erdman
Mar 20, 1999·The Journal of Nutrition·K D Setchell, A Cassidy
Apr 1, 1999·Menopause : the Journal of the North American Menopause Society·S WashburnM Anthony
Sep 9, 1999·The American Journal of Clinical Nutrition·M J Messina
Feb 5, 2000·Biochemical Pharmacology·E Sugimoto, M Yamaguchi
Jan 16, 2002·Menopause : the Journal of the North American Menopause Society·Ivy W KamCandy Tsourounis
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Mar 1, 2003·Maturitas·Wolfgang WuttkeDana Seidlová-Wuttke
Mar 1, 2003·Maturitas·Hubertus JarryWolfgang Wuttke
Jun 19, 2003·Journal of the National Cancer Institute·Seiichiro YamamotoUNKNOWN Japan Public Health Center-Based Prospective Study on Cancer Cardiovascular Diseases Group
Jan 8, 2004·JAMA : the Journal of the American Medical Association·Adam L HershRandall S Stafford
Feb 28, 2004·The Journal of Nutrition·Sophie DesrochesBenoît Lamarche
Apr 8, 2004·JAMA : the Journal of the American Medical Association·Heidi D Nelson
Aug 17, 2004·European Journal of Nutrition·Eva Lydeking-OlsenTrine Holm-Jensen
May 7, 2005·The Journal of Steroid Biochemistry and Molecular Biology·A MatsumuraP D Darbre
Apr 12, 2006·Menopause : the Journal of the North American Menopause Society·Alfredo Morabia, Michael C Costanza
Apr 12, 2006·Menopause : the Journal of the North American Menopause Society·Byung M KangJung G Kim
May 30, 2006·Journal of Ethnopharmacology·Suchinda MalaivijitnondWichai Cherdshewasart
Jun 27, 2006·The Journal of Reproduction and Development·Hataitip TrisomboonKazuyoshi Taya
Aug 26, 2006·Journal of Pharmaceutical and Biomedical Analysis·Wichai CherdshewasartWinai Dahlan
Apr 7, 2007·The American Journal of Clinical Nutrition·Kyoko TakuShaw Watanabe
Apr 7, 2007·Menopause : the Journal of the North American Menopause Society·Jittima ManonaiHathai Theppisai

❮ Previous
Next ❯

Citations

Sep 28, 2010·Archives of Gynecology and Obstetrics·Phongthorn VirojchaiwongArunporn Itharat
Mar 31, 2012·Frontiers of Medicine·Suchinda Malaivijitnond
Dec 23, 2008·Menopause : the Journal of the North American Menopause Society·Jittima ManonaiKlaus Peter Jünemann
May 23, 2014·Journal of Dietary Supplements·Catherine UlbrichtRegina C Windsor
Nov 5, 2014·Luminescence : the Journal of Biological and Chemical Luminescence·Gorawit YusakulWaraporn Putalun
Jul 19, 2014·Bioscience, Biotechnology, and Biochemistry·Jutarmas JungsukcharoenChuenchit Boonchird
Dec 23, 2009·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C BoonchirdW Cherdshewasart
Jun 15, 2018·BMC Public Health·Nucharapon LiangruenromZeljko Pedisic
Dec 11, 2013·The Cochrane Database of Systematic Reviews·Anne LethabyJulie Brown
Oct 18, 2016·Menopause : the Journal of the North American Menopause Society·Narathorn SuwanveshWichai Cherdshewasart
May 27, 2021·Climacteric : the Journal of the International Menopause Society·M J Lindermann Peressoni TeixeiraT Colonetti
Jun 3, 2021·Nutrients·Wojciech SłupskiBeata Nowak
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yaowared ChulikhitOrawan Monthakantirat

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.